This week in Other Barks & Bites: three bills with bipartisan backing that would impact access to generics and pharmaceutical R&D are introduced into the U.S. Senate; the European Patent Office announces the first administration of Paper F on modern examination techniques as part of the EQE; Tencent will invest $1.25B USD into a new Ubisoft video gaming subsidiary; the Federal Circuit upholds findings from the District of New Jersey that an ANDA label proposed by Mylan will induce infringement of antipsychotic treatment patent claims; a Texas patent attorney is ordered to pay Google $124K in attorney’s fees for filing false patent infringement allegations; and more.
Recent Posts
- Other Barks & Bites for Friday, August 29: CAFC Affirms Prosecution Laches Ruling Against Hyatt; Trump Admin Cancels USPTO CBA; Second Circuit Affirms Lack of Standing in Ripple Trademark Case
- CAFC Dodges Key Issues in Reversing District Court Finding for Google on Prosecution Laches
- CAFC Corrects PTAB’s Inventorship Analysis in First Appeal of AIA Derivation Proceeding
- Brunetti’s Back: Split CAFC Rejects Most of Scandalous Trademark Applicant’s Arguments But Remands for Second Chance at TTAB
- CAFC is Unconvinced by Claim Construction Challenges to ITC’s Robotics Patent Infringement Finding